Dyne Therapeutics (DYN) PT Raised to $35 at RBC Capital
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $18.21 -1.14%
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
RBC Capital analyst Luca Issi raised the price target on Dyne Therapeutics (NASDAQ: DYN) to $35.00 (from $30.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Dyne Therapeutics (DYN) PT Lowered to $30 at RBC Capital Following NVS Setback
- Restoration Hardware (RH) PT Lowered to $81 at BNP Paribas Exane
- Destination XL Group (DXLG) PT Lowered to $1.25 at DA Davidson on Weak Consumer Spending
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
